Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cognitive Remediation Therapy for Participants With Late-Life Schizophrenia

NCT03695614 is registered in ClinicalTrials.gov with Centre for Addiction and Mental Health as lead sponsor.

NCT NCT03695614
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03695614 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cognitive Remediation Therapy for Participants With Late-Life Schizophrenia
Lead sponsor
Centre for Addiction and Mental Health
Phase
Not applicable
Overall status
Completed
Start date
October 24, 2018
Completion date
March 12, 2020
Enrollment
34 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive deficit, cognitive remediation, functional impairment, late life schizophrenia, schizophrenia